5-Bromo-2-fluorobenzonitrile | CAS:179897-89-3

We serve 5-Bromo-2-fluorobenzonitrile CAS:179897-89-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
5-Bromo-2-fluorobenzonitrile

Chemical Name:5-Bromo-2-fluorobenzonitrile
CAS.NO:179897-89-3
Synonyms:5-Bromo-2-fluorobenzonitrile
2-Fluoro-5-bromobenzonitrile
3-cyano-4-flurobromobenzene
 
Physical and Chemical Properties:
Density 1.7±0.1 g/cm3
Boiling Point 220.4±20.0 °C at 760 mmHg
Melting Point 76-81 °C
Molecular Formula C7H3BrFN
Molecular Weight 200.008
Flash Point 87.1±21.8 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.578
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Febuxostat(CAS:144060-53-7).



Contact us for information like 5-Bromo-2-fluorobenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-cyano-4-flurobromobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluoro-5-bromobenzonitrile Use and application,5-Bromo-2-fluorobenzonitrile technical grade,usp/ep/jp grade.


Related News: Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.tert-butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate manufacturer TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment.4-Pentyloxyphenylboronic acid supplier TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment.1-Bromo-2-chloroethane vendor At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.